Dalfampridine may worsen pre-existing trigeminal neuralgia..

Dalfampridine, or Ampyra, is a potassium channel blocker that is shown to improve visual function, motor skills and relieve fatigue in MS patients.

Dalfampridine may worsen pre-existing trigeminal neuralgia..

Postby MSUK » Wed Oct 25, 2017 8:00 am

Dalfampridine may worsen pre-existing trigeminal neuralgia in MS patients #ECTRIMS

A study that set out to discover whether trigeminal neuralgia emerges or worsens with the use of dalfampridine in MS patients has suggested that it may worsen pre-existing trigeminal neuralgia or trigger new trigeminal neuralgia symptoms...Read more - http://www.ms-uk.org/dalfampridine-may-worsen-pre-existing-trigeminal-neuralgia-ms-patients-ectrims

MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm


Re: Dalfampridine may worsen pre-existing trigeminal neuralg

Postby THX1138 » Thu Oct 26, 2017 12:54 pm

Dalfampridine: old bird poison helps MS patients walking..
In Annels of neurology an editorial on 4-Aminopyridine: New Life For an Old Drug. Fampiridine we called in in the past, it was an old bird poising at one time long ago. I have reviewed clinical data of that old potassium channel inhibitor for symptomatic improvement of MS many years ago, in order to possibly licence it in for a certain pharmaceutical company. You could function a bit better, due to an improvement of impulse conductance of the nerves. At that time, many, many years ago, I felt that the symptomatic improvement was too little and the side effects to troublesome to put development energy into the drug. Since then various pharmaceutical industries must have looked into the files of fampiridine in MS. Now, the FDA approved the drug for walking difficulties in patients suffering from MS.
http://www.neuropathie.nu/research-deve ... lking.html
Family Elder
Posts: 694
Joined: Tue May 14, 2013 2:00 pm

Return to Ampyra


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service